ZIM Laboratories Limited (NSE:ZIMLAB)
80.00
-1.89 (-2.31%)
Mar 28, 2025, 3:30 PM IST
ZIM Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Operating Revenue | 3,882 | 3,674 | 3,985 | 3,334 | 3,073 | 2,777 | Upgrade
|
Other Revenue | 0.93 | 0.93 | 0.82 | 0.82 | 0.82 | 0.87 | Upgrade
|
Revenue | 3,883 | 3,675 | 3,986 | 3,335 | 3,073 | 2,778 | Upgrade
|
Revenue Growth (YoY) | 9.35% | -7.80% | 19.52% | 8.51% | 10.63% | -17.18% | Upgrade
|
Cost of Revenue | 1,859 | 1,815 | 2,072 | 1,670 | 1,635 | 1,479 | Upgrade
|
Gross Profit | 2,024 | 1,860 | 1,914 | 1,665 | 1,438 | 1,299 | Upgrade
|
Selling, General & Admin | 612.71 | 554.67 | 514.55 | 414.78 | 368.46 | 371.37 | Upgrade
|
Other Operating Expenses | 949.38 | 877.91 | 871.97 | 839.1 | 664.69 | 681.86 | Upgrade
|
Operating Expenses | 1,760 | 1,603 | 1,561 | 1,415 | 1,198 | 1,197 | Upgrade
|
Operating Income | 263.31 | 256.66 | 352.59 | 250.31 | 240.55 | 102.01 | Upgrade
|
Interest Expense | -97.14 | -58.82 | -49.7 | -71.69 | -95.1 | -113.58 | Upgrade
|
Interest & Investment Income | 1.36 | 1.36 | 3.43 | 2.9 | 6.87 | 3.93 | Upgrade
|
Currency Exchange Gain (Loss) | 38.06 | 38.06 | 55.49 | 38.54 | 13.94 | 19.48 | Upgrade
|
Other Non Operating Income (Expenses) | 3.57 | -0.68 | -1.66 | -9.6 | -12.15 | -10.88 | Upgrade
|
EBT Excluding Unusual Items | 209.16 | 236.58 | 360.15 | 210.46 | 154.12 | 0.96 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.16 | -0.16 | - | - | - | -0.05 | Upgrade
|
Asset Writedown | - | - | -6.6 | -0.03 | - | -0.22 | Upgrade
|
Other Unusual Items | - | - | - | - | -51.81 | - | Upgrade
|
Pretax Income | 209.01 | 236.42 | 353.55 | 210.43 | 102.31 | 0.69 | Upgrade
|
Income Tax Expense | 55.35 | 63.96 | 109.21 | 64.92 | 29.14 | -32.28 | Upgrade
|
Earnings From Continuing Operations | 153.66 | 172.46 | 244.35 | 145.5 | 73.18 | 32.97 | Upgrade
|
Minority Interest in Earnings | 0 | 0 | - | - | - | - | Upgrade
|
Net Income | 153.66 | 172.46 | 244.35 | 145.5 | 73.18 | 32.97 | Upgrade
|
Net Income to Common | 153.66 | 172.46 | 244.35 | 145.5 | 73.18 | 32.97 | Upgrade
|
Net Income Growth | -6.29% | -29.42% | 67.93% | 98.84% | 121.97% | -78.51% | Upgrade
|
Shares Outstanding (Basic) | 49 | 49 | 49 | 49 | 49 | 49 | Upgrade
|
Shares Outstanding (Diluted) | 49 | 49 | 49 | 49 | 49 | 49 | Upgrade
|
Shares Change (YoY) | 0.20% | - | - | 0.09% | -0.01% | -0.01% | Upgrade
|
EPS (Basic) | 3.15 | 3.54 | 5.01 | 2.99 | 1.50 | 0.68 | Upgrade
|
EPS (Diluted) | 3.15 | 3.54 | 5.01 | 2.99 | 1.50 | 0.68 | Upgrade
|
EPS Growth | -6.34% | -29.35% | 67.77% | 99.08% | 121.66% | -78.52% | Upgrade
|
Free Cash Flow | - | -576.45 | 15 | 339.81 | 253.74 | 33.88 | Upgrade
|
Free Cash Flow Per Share | - | -11.83 | 0.31 | 6.97 | 5.21 | 0.70 | Upgrade
|
Gross Margin | 52.12% | 50.60% | 48.01% | 49.93% | 46.80% | 46.77% | Upgrade
|
Operating Margin | 6.78% | 6.98% | 8.85% | 7.51% | 7.83% | 3.67% | Upgrade
|
Profit Margin | 3.96% | 4.69% | 6.13% | 4.36% | 2.38% | 1.19% | Upgrade
|
Free Cash Flow Margin | - | -15.68% | 0.38% | 10.19% | 8.26% | 1.22% | Upgrade
|
EBITDA | 387.88 | 390.59 | 499 | 387.91 | 380.7 | 235.61 | Upgrade
|
EBITDA Margin | 9.99% | 10.63% | 12.52% | 11.63% | 12.39% | 8.48% | Upgrade
|
D&A For EBITDA | 124.58 | 133.94 | 146.41 | 137.6 | 140.14 | 133.6 | Upgrade
|
EBIT | 263.31 | 256.66 | 352.59 | 250.31 | 240.55 | 102.01 | Upgrade
|
EBIT Margin | 6.78% | 6.98% | 8.85% | 7.51% | 7.83% | 3.67% | Upgrade
|
Effective Tax Rate | 26.48% | 27.05% | 30.89% | 30.85% | 28.48% | - | Upgrade
|
Revenue as Reported | 3,938 | 3,726 | 4,049 | 3,378 | 3,096 | 2,823 | Upgrade
|
Advertising Expenses | - | 19.11 | 19.14 | 9.03 | 7.96 | 15.68 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.